N-cadherin: target for cancer diagnosis and therapy

Details for Australian Patent Application No. 2009313197 (hide)

Owner The Regents of The University of California

Inventors Reiter, Robert E.

Agent Spruson & Ferguson

Pub. Number AU-A-2009313197

PCT Pub. Number WO2010/054397

Priority 12/268,302 10.11.08 US

Filing date 10 November 2009

Wipo publication date 14 May 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 July 2011 PCT application entered the National Phase

  PCT publication WO2010/054397 Priority application(s): WO2010/054397

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313198-Compounds useful as inhibitors of ATR kinase

2009313191-Method and apparatus of transition to a battery efficient state or configuration by indicating end of data transmission in long term evolution